Stock NVNO ENVVENO MEDICAL CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Revisions enVVeno Medical Corporation

Equities

NVNO

US29415J1060

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-22 pm EDT 		5-day change 1st Jan Change
4.91 USD +6.28% Intraday chart for enVVeno Medical Corporation -0.20% -4.47%
Apr. 16 EnVVeno Medical Corporation Announces Additional Topline Efficacy Data from the VenoValve U.S. Pivotal Trial to Be Presented at the 46th Annual Charing Cross Symposium on April 24, 2024 CI
Apr. 09 EnVVeno Medical Corporation Appoints Andrew Cormack as Its Chief Commercial Officer CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

  1. Stock Market
  2. Equities
  3. NVNO Stock
  4. Revisions enVVeno Medical Corporation